Bexobrutideg, a bioavailable agent, was granted orphan drug designation by the FDA for Waldenström macroglobulinemia, a type ...

The FDA has granted orphan drug designation to PEP-010 for pancreatic cancer, advancing its development as a potential novel ...

As Colorectal Cancer Awareness Month highlights the importance of early detection and advancements in treatment, according to ...

Years after losing my brother to Hodgkin’s lymphoma, I learned something about how he felt facing a terminal diagnosis by ...

Among patients with renal cell carcinoma, those with larger tumors may yield the most benefit from SBRT compared with other ...